Delivery Order 75F40121D00009-75F40125F19006
Award Date
7/2/25
Potential Completion Date
9/29/25
Potential Value
$34K
Federal Agency
Food and Drug Administration
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a division of Qiagen N.V., for the purchase of molecular biology reagents. The order is placed against Qiagen's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract #75F40121D00009. The contract has a ceiling value of $93,146.18 and a period of performance through June 14, 2025. Qiagen, as a prime contractor, has provided similar products and services to a variety of federal agencies,...
This is a $404,000.00 firm fixed-price delivery order contract awarded by the Headquarters Division of a civilian federal agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is for the supply of QIAGEN reagents and consumables, with a period of performance through April 2, 2026. The contract does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Delivery Order contract to Qiagen, LLC, a division of Qiagen N.V., for the purchase of molecular biology reagents. The $149,040.91 contract has a completion date of September 26, 2022. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has previously provided products and services like DNA/RNA extraction kits,...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
This is a federal contract award to Qiagen, LLC, a division of the biotechnology company Qiagen N.V. The contract, awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), has a ceiling value of $107,401.82 and is a firm fixed-price purchase order with an ultimate completion date of August 22, 2019. The contract provides for the addition of funding to an original requisition, without any set-aside designation. Qiagen, a...
This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
This is a delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $27,299.50 firm fixed price contract does not have a set-aside designation. Qiagen has provided a range of goods and services to support federal biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing,...
This is a $10,768 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the provision of Qiagen's clinical insight analysis products and services, with a period of performance through September 28, 2026. Qiagen, a foreign-owned, for-profit manufacturer, specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic testing solutions. The contract, valued at $29,939.02, is for the provision of reagents and consumables. It has a performance period extending until April 11, 2025. Qiagen has an extensive portfolio of federal contracts and Indefinite Delivery Vehicles (IDVs) with agencies such as the FBI, Department of...